CENTENE ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Centene Corporation and Encourages Investors to Contact the Firm

Core Viewpoint - A class action lawsuit has been filed against Centene Corporation for allegedly misleading investors about its revenue outlook and growth projections during the class period from December 12, 2024, to June 30, 2025 [1][3]. Summary by Relevant Sections Lawsuit Details - The lawsuit was initiated by Bragar Eagel & Squire, P.C. on behalf of individuals and entities that acquired Centene securities during the specified class period [1]. - Investors have until September 8, 2025, to apply to be appointed as lead plaintiff in the lawsuit [1]. Allegations Against Centene - The complaint claims that Centene misrepresented its revenue outlook and growth potential, while promoting favorable enrollment rates and low morbidity [3]. - A preliminary analysis indicated that over two-thirds of Centene's marketplace share experienced lower-than-expected enrollment and increased morbidity [3]. Impact of Guidance Withdrawal - On July 1, 2025, Centene withdrew its 2025 guidance, revealing that its market growth across 22 states (72% of its marketplace membership) was below expectations [4]. - The revised guidance indicated a reduction to approximately $1.8 billion in revenue and an adjusted diluted EPS of $2.75 [4]. - Following this announcement, Centene's stock price plummeted from $56.65 per share to $44.78 per share, marking a decline of over 40% [4].